109 results
Page 6 of 6
6-K
gw7 5ki0a
10 Aug 05
6K Report
12:00am
6-K
idvwsh662s5ama
17 May 05
Teva's Fenofibrate Product Receives Final Approval; Seeks Three Times Its Lost Profits In Antitrust Lawsuit Against Abbott
12:00am
6-K
8ot6t gypklrz
12 May 04
Teva 6K Q1 04
12:00am
6-K
9137rupv4vh98p0ol0
15 Mar 04
the Purpose of This Filing on Form 6-K Is to File the 2003 Audited Financial Statements of Sicor Inc., Which the Registrant Acquired on January 22, 2004
12:00am
6-K
4fzkqs 07
12 Nov 03
Third Quarter 2003 - Form 6K
12:00am
6-K
nazgg1 5u3411c
4 Aug 03
Second Quarter 2003 - Form 6K
12:00am
6-K
ksbww ixa
27 Mar 03
Moexipril & Ribavirin (2 Different PRS)
12:00am
6-K
99to6rgwahmc j4qzk
27 Nov 02
Teva Confirms Exercise of Option Under Collaboration with Impax Laboratories, Inc.
12:00am